Integrated analyses of gene expression, copy number, and methylation profiles in osteosarcoma cell lines has revealed a potential role for gene silencing and chromosomal aberrations in osteosarcoma tumorigenesis, particularly in the known oncoprotein c-Myc [7,9]. This evidence concerns the gene MYC and osteosarcoma.